These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2828747)

  • 21. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin resistance in secondary hypertension.
    Shamiss A; Carroll J; Rosenthal T
    Am J Hypertens; 1992 Jan; 5(1):26-8. PubMed ID: 1736930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
    Connell JM; Jardine A; Fraser R
    Adv Nephrol Necker Hosp; 1990; 19():69-77. PubMed ID: 2154082
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.
    Sutherland DJ; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1966 Nov; 95(22):1109-19. PubMed ID: 4288576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone-suppressible hyperaldosteronism: a large new kindred.
    O'Mahony S; Burns A; Murnaghan DJ
    J Hum Hypertens; 1989 Aug; 3(4):255-8. PubMed ID: 2552113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermineralocorticoidism.
    Biglieri EG; Slaton PE; Schambelan M; Kronfield SJ
    Am J Med; 1968 Aug; 45(2):170-5. PubMed ID: 4299067
    [No Abstract]   [Full Text] [Related]  

  • 27. Is aldosteronism important in the maintenance of arterial blood pressure and electrolyte balance during sodium depletion?
    Lohmeier TE; Kastner PR; Smith MJ; Guyton AC
    Hypertension; 1980; 2(4):497-505. PubMed ID: 6995290
    [No Abstract]   [Full Text] [Related]  

  • 28. Renovascular hypertension: a paradigm for all hypertension.
    Laragh JH
    J Hypertens Suppl; 1986 Oct; 4(4):S79-88. PubMed ID: 3534186
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal function curve in patients with secondary forms of hypertension.
    Kimura G; Saito F; Kojima S; Yoshimi H; Abe H; Kawano Y; Yoshida K; Ashida T; Kawamura M; Kuramochi M
    Hypertension; 1987 Jul; 10(1):11-5. PubMed ID: 3298041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma renin activity, secondary aldosteronism, and hypertension.
    Chauvel PJ; Beveridge J; Stokes GS
    Am J Dis Child; 1970 Feb; 119(2):159-63. PubMed ID: 5410567
    [No Abstract]   [Full Text] [Related]  

  • 31. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.
    Laragh JH; Baer L; Brunner HR; Buhler FR; Sealey JE; Vaughan ED
    Am J Med; 1972 May; 52(5):633-52. PubMed ID: 4337477
    [No Abstract]   [Full Text] [Related]  

  • 32. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
    Gill JR; Bartter FC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
    Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
    HOFFMEISTER W
    Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
    Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.
    Conway J
    Brux Med; 1973 Nov; Spec No(0):87-98. PubMed ID: 4371910
    [No Abstract]   [Full Text] [Related]  

  • 38. Dexamethasone-suppressible hyperaldosteronism.
    New MI; Siegal EJ; Peterson RE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):93-100. PubMed ID: 4351777
    [No Abstract]   [Full Text] [Related]  

  • 39. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension.
    Pessina AC; Sacchetto A; Rossi GP
    Adv Exp Med Biol; 1997; 432():63-9. PubMed ID: 9433512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluid homeostasis and haemodynamics during sodium restriction in hypertensive men.
    Fagerberg B; Andersson OK; Persson B; Hedner T; Hedner J; Towle A
    J Hypertens Suppl; 1985 Dec; 3(3):S327-9. PubMed ID: 2856729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.